Johnson & Johnson (ETR:JNJ)
Germany
· Delayed Price · Currency is EUR 152.08
+0.66 (0.44%)
Mar 31, 2025, 2:44 PM CET
Johnson & Johnson Employees
Johnson & Johnson had 138,100 employees as of December 29, 2024. The number of employees increased by 6,200 or 4.70% compared to the previous year.
Employees
138,100
Change (1Y)
6,200
Growth (1Y)
4.70%
Revenue / Employee
€616,730
Profits / Employee
€97,668
Market Cap
364.22B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 138,100 | 6,200 | 4.70% |
| Dec 31, 2023 | 131,900 | -20,800 | -13.62% |
| Jan 1, 2023 | 152,700 | 11,000 | 7.76% |
| Jan 2, 2022 | 141,700 | 7,200 | 5.35% |
| Jan 3, 2021 | 134,500 | 2,300 | 1.74% |
| Dec 29, 2019 | Pro | Pro | Pro |
| Dec 30, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Jan 1, 2017 | Pro | Pro | Pro |
| Jan 3, 2016 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Merck KGaA | 59,020 |
| Siemens Healthineers AG | 72,000 |
| Fresenius SE & Co. KGaA | 193,865 |
| Bayer Aktiengesellschaft | 90,587 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fresenius Medical Care AG | 111,513 |
| Carl Zeiss Meditec AG | 5,730 |
| Fielmann Group AG | 23,412 |
Johnson & Johnson News
- 1 day ago - Johnson & Johnson (JNJ) Evaluated Amidst Tariff Talks - GuruFocus
- 2 days ago - If I Could Only Choose 5 Dividend Stocks For My Retirement Portfolio - Seeking Alpha
- 2 days ago - Johnson & Johnson Needs Time To Consolidate (Technical Analysis And Downgrade) - Seeking Alpha
- 2 days ago - Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case - Reuters
- 3 days ago - Trump Weighs Tariffs on Ireland's Pharma Industry. How to Play the Sector. - Market Watch
- 4 days ago - Strategically Building A $100,000 Dividend Portfolio For Attractive Income And Strong Risk-Adjusted Returns - Seeking Alpha
- 4 days ago - RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) outperforms osimertinib with a significant and unprecedented overall survival benefit in patients with EGFR-mutated non-small cell lung cancer - PRNewsWire
- 4 days ago - Tech struggles while oil and financials rise: A comprehensive market snapshot - Forexlive